Dr. Agarwal's Eye Hospital and Dr. Agarwal's Health Care to Merge in Amalgamation Scheme

Dr. Agarwal's Eye Hospital and Dr. Agarwal's Health Care to Merge in Amalgamation Scheme​

Dr. Agarwal's Eye Hospital Limited (AEHL) and Dr. Agarwal's Health Care Limited (AHCL) are undergoing a proposed amalgamation designed to consolidate their businesses and create a unified, larger entity. The merger, which aims to streamline operations and generate significant efficiencies, is subject to the approval of their respective shareholders and creditors.

The process is proceeding following an Order issued by the National Company Law Tribunal (NCLT), Chennai Bench, which directed the convening of separate meetings for the Equity Shareholders, Secured Creditors, and Unsecured Creditors of both entities.

Key Transaction Details​

The core of the amalgamation is the transfer of AEHL's business operations into AHCL. This transaction results in the following share exchange ratio, determined based on valuations by registered valuers:


This structure means that the existing shareholders of AEHL will receive fully paid-up equity shares of AHCL upon the scheme becoming effective.

Financial and Operational Impact​

The amalgamation aims to enhance operational and financial efficiencies by consolidating resources and simplifying the governance structure.

Financial details concerning the pre- and post-merger net worth of the companies are as follows:


The transfer of assets and liabilities is structured as follows:


The combination is projected to provide an immediate boost to the Transferee Company's net worth from ₹ 1973.87 crores to ₹ 2225.44 crores.

Rationale and Strategic Benefits​

The Board of Directors of both AHCL and AEHL advised that the merger is anticipated to generate substantial benefits, including:

1. Operational Efficiencies: Integration of operations will lead to standardized protocols, enhanced organizational and financial efficiency, and cost savings through the elimination of multiple administrative functions.
2. Capital Allocation: The combined entity will benefit from a unified capital structure, allowing for more efficient deployment of capital for strategic investments and sustained growth.
3. Shareholder Value: The scheme is expected to be accretive to earnings per share (EPS) starting from the first year of implementation.

Meeting Schedule and Voting Details​

The NCLT has set the following timelines for the relevant parties to consider and approve the scheme:

• Equity Shareholders' Meeting (AEHL): Thursday, July 02, 2026, at 09:00 A.M. IST.
• Remote e-voting Window: The remote e-voting period commenced on Sunday, June 07, 2026, and concluded on Wednesday, July 01, 2026.
• Eligible Shareholders Cut-off Date: Wednesday, June 03, 2026, determined the eligible voters.

The amalgamation is conditional upon the necessary approvals and the passing of the resolution by the respective public shareholders, where the votes cast in favor must exceed those cast against.

***

Data Snapshot: Company Financials (as of Dec 31, 2025)

DRAGARWQ Stock Price Movement​

As of 1:58 PM, shares of Dr Agarwals Eye Hospital Limited are gaining momentum in live trading, currently up 1.08% at ₹5020. The stock has seen activity in the market, with 825 shares traded thus far today.